Gurushankar Chandramouly
5PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 22, 2025
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors.Gurushankar Chandramouly, William Fried, John Gordon
|Dec 08, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams
|Apr 14, 2023
Author Correction: Polλ promotes microhomology-mediated end-joining.Gurushankar Chandramouly, Joonas Jamsen, Nikita Borisonnik
|Dec 19, 2022
Polλ promotes microhomology-mediated end-joining.Gurushankar Chandramouly, Joonas Jamsen, Nikita Borisonnik
|Jun 12, 2021
Polθ reverse transcribes RNA and promotes RNA-templated DNA repair.Gurushankar Chandramouly, Jiemin Zhao, Shane McDevitt
Pageof 1
Frequent Collaborators
4 joint publications
Richard T Pomerantz
2 joint publications
Tatiana Kent
2 joint publications
Samuel H Wilson
2 joint publications
Joonas Jamsen
1 joint publications
Christine M Eischen
1 joint publications
Shane McDevitt
1 joint publications
Timur Rusanov
1 joint publications
Taylor Treddinick
1 joint publications
Felicia Wednesday Lopezcolorado
1 joint publications
Jacklyn Huhn
